208 related articles for article (PubMed ID: 27594784)
1. Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
Chacko A; Staines DR; Johnston SC; Marshall-Gradisnik SM
Gene Regul Syst Bio; 2016; 10():85-93. PubMed ID: 27594784
[TBL] [Abstract][Full Text] [Related]
2. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
[TBL] [Abstract][Full Text] [Related]
3. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Huth TK; Staines D; Marshall-Gradisnik S
J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
[TBL] [Abstract][Full Text] [Related]
5. Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.
Eaton-Fitch N; Du Preez S; Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
J Transl Med; 2022 Feb; 20(1):94. PubMed ID: 35172836
[TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Balinas C; Cabanas H; Staines D; Marshall-Gradisnik S
J Transl Med; 2019 Dec; 17(1):401. PubMed ID: 31796045
[TBL] [Abstract][Full Text] [Related]
7. The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP
Eaton-Fitch N; Cabanas H; du Preez S; Staines D; Marshall-Gradisnik S
J Transl Med; 2021 Jul; 19(1):306. PubMed ID: 34266470
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome.
Marshall-Gradisnik S; Huth T; Chacko A; Johnston S; Smith P; Staines D
Appl Clin Genet; 2016; 9():39-47. PubMed ID: 27099524
[TBL] [Abstract][Full Text] [Related]
9. Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Du Preez S; Eaton-Fitch N; Smith PK; Marshall-Gradisnik S
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509075
[TBL] [Abstract][Full Text] [Related]
10. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S
BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879
[TBL] [Abstract][Full Text] [Related]
11. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.
Nguyen T; Staines D; Nilius B; Smith P; Marshall-Gradisnik S
Biol Res; 2016 May; 49(1):27. PubMed ID: 27245705
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
[TBL] [Abstract][Full Text] [Related]
13. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.
Nguyen T; Johnston S; Clarke L; Smith P; Staines D; Marshall-Gradisnik S
Clin Exp Immunol; 2017 Feb; 187(2):284-293. PubMed ID: 27727448
[TBL] [Abstract][Full Text] [Related]
14. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
Front Immunol; 2021; 12():687806. PubMed ID: 34326841
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
Front Immunol; 2019; 10():2545. PubMed ID: 31736966
[TBL] [Abstract][Full Text] [Related]
16. Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
Huth TK; Brenu EW; Staines DR; Marshall-Gradisnik SM
Gene Regul Syst Bio; 2016; 10():43-9. PubMed ID: 27346947
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.
Eaton-Fitch N; du Preez S; Cabanas H; Staines D; Marshall-Gradisnik S
Syst Rev; 2019 Nov; 8(1):279. PubMed ID: 31727160
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.
Brenu EW; van Driel ML; Staines DR; Ashton KJ; Hardcastle SL; Keane J; Tajouri L; Peterson D; Ramos SB; Marshall-Gradisnik SM
J Transl Med; 2012 May; 10():88. PubMed ID: 22571715
[TBL] [Abstract][Full Text] [Related]
19. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
Petty RD; McCarthy NE; Le Dieu R; Kerr JR
PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
